These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34900441)

  • 1. Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening.
    Yan T; Wang K; Zhao Q; Zhuang J; Shen H; Ma G; Cong L; Du J
    PeerJ; 2021; 9():e12536. PubMed ID: 34900441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
    Cheng L; Han T; Chen B; Nie K; Peng W
    BMC Cancer; 2021 Jul; 21(1):794. PubMed ID: 34238250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
    Ye M; Wang S; Qie JB; Sun PL
    Front Oncol; 2021; 11():765484. PubMed ID: 34671565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.
    Liu J; Yin J; Wang Y; Cai L; Geng R; Du M; Zhong Z; Ni S; Huang X; Yu H; Bai J
    Biol Proced Online; 2022 Jul; 24(1):9. PubMed ID: 35836132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
    Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W
    Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer.
    Yang S; Zou X; Yang H; Li J; Zhang A; Zhang L; Li C; Zhu L; Ma Z
    Front Genet; 2022; 13():854211. PubMed ID: 35571043
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer.
    Zhang L; Ding D; Liu J; Liu J; Wang N; Liu J
    Medicine (Baltimore); 2022 Jul; 101(26):e29759. PubMed ID: 35776987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
    Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
    Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker.
    Wang R; Liu N; Li G; Liu J; Ma X; Liu X; Li J
    Front Genet; 2023; 14():1160599. PubMed ID: 37091809
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis.
    Kang K; Wu J; Mao Y; Kai J; Chen S; Xiong F
    J Coll Physicians Surg Pak; 2023 Sep; 33(9):964-971. PubMed ID: 37691355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis.
    Ye T; Li LL; Peng XM; Li Q
    Dis Markers; 2021; 2021():8565943. PubMed ID: 35003394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma.
    Tsai JC; Saad OA; Magesh S; Xu J; Lee AC; Li WT; Chakladar J; Fuster MM; Chang EY; Wang-Rodriguez J; Ongkeko WM
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
    Xiao J; Liu Y; Yi J; Liu X
    Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.
    Ma J; Chen S; Hao L; Sheng W; Chen W; Ma X; Zhang B; Ma D; Huang G
    J Cell Mol Med; 2020 Jun; 24(11):6472-6484. PubMed ID: 32368852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
    Feng H; Zhang X; Lai W; Wang J
    Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
    Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
    Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Feng G; Wang T; Xue F; Qi Y; Wang R; Yuan H
    Head Neck; 2021 Dec; 43(12):3820-3831. PubMed ID: 34569097
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gu X; Wang L; Boldrup L; Coates PJ; Fahraeus R; Sgaramella N; Wilms T; Nylander K
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer.
    Liu HY; Lu SR; Guo ZH; Zhang ZS; Ye X; Du Q; Li H; Wu Q; Yu B; Zhai Q; Liu JL
    J Investig Med; 2020 Jan; 68(1):52-59. PubMed ID: 31371390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.